Results 141 to 150 of about 4,984,276 (289)

Urticarial vasculitis coexisting with primary myelofibrosis – a case report

Przegląd Dermatologiczny, 2017
Introduction . Urticarial vasculitis is a subtype of cutaneous leukocytoclastic vasculitis. The disease often accompanies systemic disorders, including hematologic malignancies, connective tissue diseases, and infectious diseases, or may be drug-induced.
Radomir Reszke, Adam Reich
doaj   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study

eJHaem, Volume 7, Issue 1, February 2026.
Nikhil Vojjala, Raj Shah, Viktoriya Gibatova, Lakshmi Kattamuri, Shubham Agrawal, Geetha Krishnamoorthy, Rushad Patell   +6 more
wiley   +1 more source

Coexistence of primary myelofibrosis and chronic lymphocytic leukemia

Blood and Lymphatic Cancer: Targets and Therapy, 2014
Sonja Burgstaller, Josef Thaler Klinikum Wels-Grieskirchen, Abteilung für Innere Medizin IV, Wels, AustriaAbstract: Coexistence of two hematologic malignancies in one patient is generally a rare phenomenon.
Burgstaller S, Thaler J
doaj  

TP53 mutations and polymorphisms in primary myelofibrosis [PDF]

, 2011
Sania S. Raza, David S. Viswanatha, Lori Frederick, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Rhett P. Ketterling, Animesh Pardanani, Ayalew Tefferi   +8 more
openalex   +1 more source

Biomolecular and histological features in pediatric essential thrombocythemia: adequacy of who diagnostic criteria [PDF]

, 2017
Myeloproliferative neoplasms (MPN), Essential Thrombocythemia (ET), Polycythemia Vera (PV) and primary myelofibrosis (PMF), are clonal disorders of the hematopoietic stem cell.
Bertozzi, Irene
core   +1 more source

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms

Annals of Hematology
Polycythemia vera (PV) and Essential thrombcythemia (ET) are myeloproliferative neoplasms (MPNs) that can progress to secondary myelofibrosis, a complication associated with increased mortality. Circulating CD34-positive cells at diagnosis can be used to
Marine Demoy, Maxence Bauvais, Agathe Vely, Thomas Nicol, Jérémie Riou, Hortense Le Jeanne, Aurélien Bauduin, Hubert Rambaud, Françoise Boyer, Franck Geneviève, Agathe Boussaroque, Marie-Christine Copin, Valérie Ugo, Corentin Orvain, Damien Luque Paz   +14 more
doaj   +1 more source

Primary myelofibrosis and the "bad seeds in bad soil" concept [PDF]

, 2012
Marie‐Caroline Le Bousse‐Kerdilès
openalex   +1 more source

Retroperitoneal extramedullary hematopoietic pseudotumor in ataxia-telangiectasia. [PDF]

, 2018
Ataxia-telangiectasia confers a significant increase in the development of several cancer types, most commonly leukemia and lymphoma. However, as the natural history for these patients is evolving and their lifespan is increasing, there is the potential ...
Bateni, Cyrus P, Canter, Robert J, Darrow, Morgan A, Evans, Christopher P, Judge, Sean James, Plescia, Trevor A   +5 more
core  

Primary Myelofibrosis in a Young Girl- A Case Report

, 2023
Homayra Tahseen Hossain, Arfa Rahman, Masudul Alam Mazumder, Mahbub Mayukh Rishad, Quazi Tarikul Islam, Mohammad Zahiruddin   +5 more
openalex   +2 more sources

Primary myelofibrosis: risk stratification by IPSS identifies patients with poor clinical outcome

Clinics, 2013
OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome.
Bruno Deltreggia Benites, Carolina Silva Costa Lima, Irene Lorand-Metze, Marcia Torresan Delamain, Gislaine Borba Oliveira, Daiane de Almeida, Carmino Antonio de Souza, Jose Vassallo, Katia Borgia Barbosa Pagnano   +8 more
doaj